| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0916 | Bcl-2 Inhibitor Pdf | Novel efficient Bcl-2 inhibitor, exhibiting high specificity and stabilizing effect toward G-quadruplexes |
|
| DCC0917 | Bcl-2 Inhibitor S1 | Novel pan-Bcl-2 family inhibitor, upregulating the BH3-only protein Noxa, which inhibits Mcl-1, inducing autophagy through (ER) stress and disruption of the interaction of Beclin 1 with Bcl-2 |
|
| DCC0918 | Bcl6-protac-15 | Novel B-Cell Lymphoma 6 (BCL6) PROTAC |
|
| DCC0919 | Bcn-e-bcn | Novel Cell-Permeable Probe for the Identification of Protein Sulfenic Acids |
|
| DCC0920 | Bcn-peg6-oh | Clearing cycloalkyne for click reaction with Azido-Warfarin WN3 or other Azido-containing drugs |
|
| DCC0921 | bcr-abl Inhibitor 9b | Novel highly potent inhibitor of breakpoint cluster region-abelson kinase (Bcr-Abl) including the T315I mutant |
|
| DCC0922 | Bcr-abl-in-y9 | Novel Bcr-Abl inhibitor, potently inhibited Bcr-AblWT and Bcr-AblT315I kinases with IC 50 of 0.043 μM and 0.17 μM, respectively |
|
| DCC0923 | bd-1008 | Potent and selective |
|
| DCC0924 | bddpm | Novel small molecule PTP1B inhibitor |
|
| DCC0925 | Bdf-9148 | Sodium channel enhancer |
|
| DCC0926 | Bdm14471 | Potent and selective hydroxamate PfAM1 inhibitor |
|
| DCC0927 | Bdm31343 | Novel EthR inhibitor, boosting antituberculous activity of ethionamide |
|
| DCC0928 | Bdm31369 | Novel activator of ethionamide |
|
| DCC0929 | Bdm31827 | Novel EthR inhibitor and ethionamide booster |
|
| DCC0930 | Bdm41906 | Novel specific bona fide EthR-inhibitor, boosting ETH 4 times in an intravenously infected TB mice model |
|
| DCC0931 | Bdoia383 | Novel CBP/p300 Bromodomains inhibitor, binding BRD4 almost identical to SGC-CBP30 |
|
| DCC0932 | beclomethasone 17-monopropionate | Active metabolite of beclomethasone dipropionate |
|
| DCC0933 | Behenyl Palmitate | Fatty Ester for Lipid Research |
|
| DCC0934 | Bemppox | Novel potent and specific inhibitor of dog gastric lipase (DGL) |
|
| DCC0935 | Benanserin Hydrochloride | Inhibitor of monoamine oxidase; Anti-serotonin agent |
|
| DCC0936 | Benazepril | Inhibitor of angiotensin-converting enzyme (ACE); Prodrug of benazeprilat |
|
| DCC0937 | Benc-511 | Novel potent PI3K inhibitor, suppressing metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop, blocking AKT phosphorylation |
|
| DCC0938 | Benfluron Hydrochloride | Novel inhibitor of HIV-1 Rev function, also acting as a cytostatic agent with substantial antiretroviral activity |
|
| DCC0939 | Benmoxin | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC0940 | Benorterone | Antiandrogen, being effective in the treatment of acne, seborrhea, and hirsutism in women |
|
| DCC0941 | Benperidol Hydrochloride | Potent D2/D4 dopamine receptor antagonist, neuroleptic and antipsychotic |
|
| DCC0942 | Benzavir-1 | anti-HSV agent |
|
| DCC0943 | Benzobicyclon | Inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), acting as a herbicide |
|
| DCC0944 | Benzphetamine Hydrochloride | Anorectic, primarily promoting weight loss through reduced appetite |
|
| DCC0945 | Benzyl Vinyl Carbonate | Useful pharmaceutical building block |
|
